Institutional Ownership Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the 1,486 institutions that hold shares in the stock, with a total of 83.7 Million shares, which have been reported (via 13F filing form) to have a value of $57.8 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Hotaling Investment Management, LLC
Wayne, PA |
Feb 14, 2023 Q4 2022 |
1,539
shares
|
$1.06 Million
0.5% of portfolio
|
Q4 2022
New holding
|
|
Fortis Capital Advisors, LLC
Reno, NV |
Nov 12, 2024 Q3 2024 |
1,539
shares
|
$1.06 Million
0.54% of portfolio
|
Q3 2024
Added 2.12%
|
|
Oddo Bhf Asset Management Sas
Paris, I0 |
Dec 03, 2024 Q3 2024 |
1,520
shares
|
$1.05 Million
0.08% of portfolio
|
Q3 2024
New holding
|
|
Snowden Capital Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
1,509
shares
|
$1.04 Million
0.05% of portfolio
|
Q3 2024
Reduced 10.6%
|
|
Moody National Bank Trust Division
|
Jan 13, 2025 Q4 2024 |
1,498
shares
|
$1.03 Million
0.11% of portfolio
|
Q4 2024
New holding
|
|
Busey Wealth Management
|
Jan 23, 2025 Q4 2024 |
1,490
shares
|
$1.03 Million
0.04% of portfolio
|
Q4 2024
Reduced 4.67%
|
|
V Square Quantitative Management LLC
Chicago, IL |
Jan 30, 2025 Q4 2024 |
1,489
shares
|
$1.03 Million
0.15% of portfolio
|
Q4 2024
Added 11.87%
|
|
Ashford Capital Management Inc
Wilmington, DE |
Nov 15, 2024 Q3 2024 |
1,483
shares
|
$1.02 Million
0.21% of portfolio
|
Q3 2024
Reduced 5.66%
|
|
Ep Wealth Advisors, LLC
Torrance, CA |
Nov 14, 2024 Q3 2024 |
1,467
shares
|
$1.01 Million
0.01% of portfolio
|
Q3 2024
Added 16.61%
|
|
Boston Trust Walden Corp
|
Jan 24, 2025 Q4 2024 |
1,453
shares
|
$1 Million
0.01% of portfolio
|
Q3 2024
Reduced 1.36%
|
|
Balboa Wealth Partners
Newport Beach, CA |
Feb 10, 2025 Q4 2024 |
1,452
shares
|
$1 Million
0.24% of portfolio
|
Q4 2024
Reduced 3.14%
|
|
Mission Creek Capital Partners, Inc.
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
1,439
shares
|
$993,428
0.36% of portfolio
|
Q3 2024
Added 1.98%
|
|
Camarda Financial Advisors, LLC
Fleming Island, FL |
Nov 12, 2024 Q3 2024 |
1,435
shares
|
$990,666
0.62% of portfolio
|
Q3 2024
Reduced 1.44%
|
|
Umpqua Bank
Lake Oswego, OR |
Oct 30, 2024 Q3 2024 |
1,426
shares
|
$984,453
0.55% of portfolio
|
Q3 2024
Added 2.3%
|
|
Analyst Ims Investment Management Services Ltd.
|
Feb 10, 2025 Q4 2024 |
1,425
shares
|
$983,763
0.04% of portfolio
|
Q1 2023
Reduced 4.17%
|
|
Vident Advisory, LLC
Alpharetta, GA |
Nov 14, 2024 Q3 2024 |
1,423
shares
|
$982,382
0.04% of portfolio
|
Q3 2024
Reduced 75.77%
|
|
Qtron Investments LLC
Boston, MA |
Nov 13, 2024 Q3 2024 |
1,415
shares
|
$976,859
0.21% of portfolio
|
Q3 2024
Reduced 23.55%
|
|
Camden Capital, LLC
|
Jan 29, 2025 Q4 2024 |
1,414
shares
|
$976,169
0.11% of portfolio
|
Q4 2024
Reduced 7.1%
|
|
Icici Prudential Asset Management CO LTD
|
Jan 31, 2025 Q4 2024 |
1,407
shares
|
$971,336
0.11% of portfolio
|
Q4 2024
Reduced 0.57%
|
|
Miracle Mile Advisors, LLC
|
Jan 13, 2025 Q4 2024 |
1,404
shares
|
$969,265
0.02% of portfolio
|
Q4 2024
Reduced 45.2%
|
|
Generali Investments Towarzystwo Funduszy Inwestycyjnych
Warsaw, R9 |
Feb 05, 2025 Q4 2024 |
1,401
shares
|
$967,194
0.58% of portfolio
|
Q4 2024
Added 27.71%
|
|
Summit Trail Advisors, LLC
New York, NY |
Jan 29, 2025 Q4 2024 |
1,396
shares
|
$963,742
0.04% of portfolio
|
Q4 2024
Added 0.43%
|
|
Knollwood Investment Advisory, LLC
Hunt Valley, MD |
Nov 14, 2024 Q3 2024 |
1,396
shares
|
$963,742
0.16% of portfolio
|
Q2 2024
Added 51.74%
|
|
Chiron Investment Management, LLC
New York, NY |
Nov 18, 2024 Q3 2024 |
1,389
shares
|
$958,910
0.52% of portfolio
|
Q3 2024
Reduced 30.31%
|
|
Weaver Capital Management LLC
Suwanee, GA |
Jan 27, 2025 Q4 2024 |
1,381
shares
|
$953,387
0.27% of portfolio
|
Q4 2024
Reduced 27.58%
|